Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
Plos One
|
September 26, 2014
Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survival
Corrado Tarella, Angela Gueli, Federica Delaini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells
Paolo Corradini, Anna Dodero, Francesco Zallio, et al.
Cancer
|
August 28, 2003
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3
Alessandra Cuttica, Francesco Zallio, Marco Ladetto, et al.
Cancers
|
September 10, 2021
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma
Daniele Caracciolo, Caterina Riillo, Giada Juli, et al.
Current HIV Research
|
June 1, 2017
High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders
Andrea Calcagno, Anna Lucchini, Daniele Caracciolo, et al.
Oncotarget
|
July 11, 2015
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts
Maria Rita Pitari, Marco Rossi, Nicola Amodio, et al.
Experimental Hematology
|
March 24, 2007
Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir
Alberto Rocci, Irene Ricca, Chiara Dellacasa, et al.
Oncotarget
|
May 21, 2014
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity
Lavinia Raimondi, Nicola Amodio, Maria Teresa Di Martino, et al.
British Journal of Haematology
|
July 1, 2026
Clinical outcomes of the chemo-free approach in relapsed/refractory follicular lymphoma: A network meta-analysis
Daniele Caracciolo, Maria Rita Lombardo, Gianluca Reitano, et al.
European Journal of Haematology
|
February 19, 2025
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives
Giulio Caridà, Enrica Antonia Martino, Antonella Bruzzese, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
Plos One
|
September 26, 2014
Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survival
Corrado Tarella, Angela Gueli, Federica Delaini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells
Paolo Corradini, Anna Dodero, Francesco Zallio, et al.
Cancer
|
August 28, 2003
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3
Alessandra Cuttica, Francesco Zallio, Marco Ladetto, et al.
Cancers
|
September 10, 2021
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma
Daniele Caracciolo, Caterina Riillo, Giada Juli, et al.
Current HIV Research
|
June 1, 2017
High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders
Andrea Calcagno, Anna Lucchini, Daniele Caracciolo, et al.
Oncotarget
|
July 11, 2015
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts
Maria Rita Pitari, Marco Rossi, Nicola Amodio, et al.
Experimental Hematology
|
March 24, 2007
Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir
Alberto Rocci, Irene Ricca, Chiara Dellacasa, et al.
Oncotarget
|
May 21, 2014
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity
Lavinia Raimondi, Nicola Amodio, Maria Teresa Di Martino, et al.
British Journal of Haematology
|
July 1, 2026
Clinical outcomes of the chemo-free approach in relapsed/refractory follicular lymphoma: A network meta-analysis
Daniele Caracciolo, Maria Rita Lombardo, Gianluca Reitano, et al.
European Journal of Haematology
|
February 19, 2025
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives
Giulio Caridà, Enrica Antonia Martino, Antonella Bruzzese, et al.
Page
of 8